BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11341500)

  • 1. Prothrombin Scranton: substitution of an amino acid residue involved in the binding of Na+ (LYS-556 to THR) leads to dysprothrombinemia.
    Sun WY; Smirnow D; Jenkins ML; Degen SJ
    Thromb Haemost; 2001 Apr; 85(4):651-4. PubMed ID: 11341500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala.
    Degen SJ; McDowell SA; Sparks LM; Scharrer I
    Thromb Haemost; 1995 Feb; 73(2):203-9. PubMed ID: 7792730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a single base substitution of the gene for prothrombin Tokushima. The application of PCR-SSCP for the genetic and molecular analysis of dysprothrombinemia.
    Iwahana H; Yoshimoto K; Shigekiyo T; Shirakami A; Saito S; Itakura M
    Int J Hematol; 1992 Feb; 55(1):93-100. PubMed ID: 1349838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin Saint-Denis: a natural variant with a point mutation resulting in Asp to Glu substitution at position 552 in prothrombin.
    Rouy S; Vidaud D; Alessandri JL; Dautzenberg MD; Venisse L; Guillin MC; Bezeaud A
    Br J Haematol; 2006 Mar; 132(6):770-3. PubMed ID: 16487178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency.
    Akhavan S; Mannucci PM; Lak M; Mancuso G; Mazzucconi MG; Rocino A; Jenkins PV; Perkins SJ
    Thromb Haemost; 2000 Dec; 84(6):989-97. PubMed ID: 11154146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe hereditary coagulation factor V deficiency caused by two novel heterozygous mutations].
    Zhou RF; Fu QH; Xu XC; Wang WB; Wu WM; Ding QL; Xie S; Zhai ZM; Hu YQ; Wang XF; Wu JS; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):129-32. PubMed ID: 15946520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and genetic analysis of dysprothrombinemia due to a novel homozygous mutation.
    Su K; Jin Y; Miao Z; Cheng X; Yang L; Wang M
    Hematology; 2017 Jul; 22(6):380-385. PubMed ID: 28196451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the VMD2 gene in thai families with best macular dystrophy.
    Atchaneeyasakul LO; Jinda W; Sakolsatayadorn N; Trinavarat A; Ruangvoravate N; Thanasombatskul N; Thongnoppakhun W; Limwongse C
    Ophthalmic Genet; 2008 Sep; 29(3):139-44. PubMed ID: 18766995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly.
    Al-Hilali A; Wulff K; Abdel-Razeq H; Saud KA; Al-Gaili F; Herrmann FH
    Thromb Haemost; 2007 Apr; 97(4):542-5. PubMed ID: 17393015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin San Antonio: a single amino acid substitution at a factor Xa activation site (Arg320 to His) results in dysprothrombinemia.
    Sun WY; Burkart MC; Holahan JR; Degen SJ
    Blood; 2000 Jan; 95(2):711-4. PubMed ID: 10627484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA-binding capacity of genetic variants of the bovine STAT5A transcription factor.
    Flisikowski K; Szymanowska M; Zwierzchowski L
    Cell Mol Biol Lett; 2003; 8(3):831-40. PubMed ID: 12949622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A point mutation of protein C gene in a congenital protein C deficiency pedigree].
    Liu L; Guo WR; He LS; Mu H; Jiang Y; Huang FQ; Li JZ
    Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):115-8. PubMed ID: 12697119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindreds.
    Chen DH; Matsushita M; Rainier S; Meaney B; Tisch L; Feleke A; Wolff J; Lipe H; Fink J; Bird TD; Raskind WH
    Arch Neurol; 2005 Apr; 62(4):597-600. PubMed ID: 15824259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and genetic analysis of a compound heterozygote for dysprothrombinemia of prothrombin Tokushima and hypoprothrombinemia.
    Iwahana H; Yoshimoto K; Shigekiyo T; Shirakami A; Saito S; Itakura M
    Am J Hum Genet; 1992 Dec; 51(6):1386-95. PubMed ID: 1334372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial gene variation in type 2 diabetes mellitus: detection of a novel mutation associated with maternally inherited diabetes in a Chinese family.
    Ma L; Wang H; Chen J; Jin W; Liu L; Ban B; Shen J; Hua Z; Chai J
    Chin Med J (Engl); 2000 Feb; 113(2):111-6. PubMed ID: 11775531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia.
    O'Marcaigh AS; Nichols WL; Hassinger NL; Mullins JD; Mallouh AA; Gilchrist GS; Owen WG
    Blood; 1996 Oct; 88(7):2611-8. PubMed ID: 8839854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor X Stockton: a mild bleeding diathesis associated with an active site mutation in factor X.
    Messier TL; Wong CY; Bovill EG; Long GL; Church WR
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):5-14. PubMed ID: 8845463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel Jk(null) alleles derived from 222C>A in Exon 5 and 896G>A in Exon 9 of the JK gene.
    Liu HM; Lin JS; Chen PS; Lyou JY; Chen YJ; Tzeng CH
    Transfusion; 2009 Feb; 49(2):259-64. PubMed ID: 18980618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder.
    Poort SR; Michiels JJ; Reitsma PH; Bertina RM
    Thromb Haemost; 1994 Dec; 72(6):819-24. PubMed ID: 7740448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.